The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

John S. Lambert

Division of Clinical Research

University of Maryland Institute of Human Virology

Baltimore

Maryland

USA

[email]@umbi.umd.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Clinical Research, University of Maryland Institute of Human Virology, Baltimore, Maryland, USA. 1999 - 2005
  • The Institute of Human Virology, University of Maryland at Baltimore School of Medicine, 21201, USA. 1997 - 2003
  • The Johns Hopkins University, Baltimore, Maryland, USA. 1998

References

  1. HIV vaccines in infants and children. Lambert, J.S. Paediatr. Drugs (2005) [Pubmed]
  2. Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection. Lambert, J.S., Harris, D.R., Stiehm, E.R., Moye, J., Fowler, M.G., Meyer, W.A., Bethel, J., Mofenson, L.M. J. Acquir. Immune Defic. Syndr. (2003) [Pubmed]
  3. A pilot study to evaluate the safety and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil. Lambert, J.S., Nogueira, S.A., Abreu, T., Machado, E.S., Costa, T.P., Bondarovsky, M., Andrade, M., Halpern, M., Barbosa, R., Perez, M. Sex. Transm. Infect (2003) [Pubmed]
  4. A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects. Lambert, J.S., Keefer, M., Mulligan, M.J., Schwartz, D., Mestecky, J., Weinhold, K., Smith, C., Hsieh, R., Moldoveanu, Z., Fast, P., Forrest, B., Koff, W. Vaccine (2001) [Pubmed]
  5. Current issues in the immunoprophylaxis of vertical transmission of HIV. Lambert, J.S., Moye, J.J. BioDrugs (1999) [Pubmed]
  6. Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218). Lambert, J.S., McNamara, J., Katz, S.L., Fenton, T., Kang, M., VanCott, T.C., Livingston, R., Hawkins, E., Moye, J., Borkowsky, W., Johnson, D., Yogev, R., Duliege, A.M., Francis, D., Gershon, A., Wara, D., Martin, N., Levin, M., McSherry, G., Smith, G. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. (1998) [Pubmed]
  7. Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious Diseases-sponsored AIDS Vaccine Evaluation Group. Lambert, J.S., Viscidi, R., Walker, M.C., Clayman, B., Winget, M., Wolff, M., Schwartz, D.H. Clin. Diagn. Lab. Immunol. (1997) [Pubmed]
 
WikiGenes - Universities